The epidemiology of cancer-associated venous thromboembolism: An update

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

The incidence of venous thromboembolism (VTE) is known to be higher in patients with malignancy as compared with the general population. It is important to understand and review the epidemiology of VTE in cancer patients because it has implications regarding treatment and prognosis. Multiple studies have shown that cancer patients who develop VTE are at higher risk for mortality. This article will focus on an update regarding the epidemiology of cancer-associated thrombosis (CT). The authors will describe factors associated with CT risk including cancer type and stage at the time of diagnosis, race and ethnicity, and cancer-directed therapy. In addition, recurrent thrombosis and the effect of thromboembolism on survival in cancer patients will also be addressed.

Original languageEnglish (US)
Pages (from-to)321-325
Number of pages5
JournalSeminars in Thrombosis and Hemostasis
Volume45
Issue number4
DOIs
StatePublished - Jan 1 2019

Fingerprint

Venous Thromboembolism
Epidemiology
Neoplasms
Thrombosis
Thromboembolism
Survival
Mortality
Incidence
Therapeutics
Population

Keywords

  • cancer-associated thrombosis
  • epidemiology
  • pulmonary embolism
  • venous thrombosis

ASJC Scopus subject areas

  • Hematology
  • Cardiology and Cardiovascular Medicine

Cite this

The epidemiology of cancer-associated venous thromboembolism : An update. / Mahajan, Anjlee; Brunson, Ann; White, Richard H; Wun, Theodore.

In: Seminars in Thrombosis and Hemostasis, Vol. 45, No. 4, 01.01.2019, p. 321-325.

Research output: Contribution to journalReview article

@article{8fbf0b69691f47738f1393c5bf4afd3c,
title = "The epidemiology of cancer-associated venous thromboembolism: An update",
abstract = "The incidence of venous thromboembolism (VTE) is known to be higher in patients with malignancy as compared with the general population. It is important to understand and review the epidemiology of VTE in cancer patients because it has implications regarding treatment and prognosis. Multiple studies have shown that cancer patients who develop VTE are at higher risk for mortality. This article will focus on an update regarding the epidemiology of cancer-associated thrombosis (CT). The authors will describe factors associated with CT risk including cancer type and stage at the time of diagnosis, race and ethnicity, and cancer-directed therapy. In addition, recurrent thrombosis and the effect of thromboembolism on survival in cancer patients will also be addressed.",
keywords = "cancer-associated thrombosis, epidemiology, pulmonary embolism, venous thrombosis",
author = "Anjlee Mahajan and Ann Brunson and White, {Richard H} and Theodore Wun",
year = "2019",
month = "1",
day = "1",
doi = "10.1055/s-0039-1688494",
language = "English (US)",
volume = "45",
pages = "321--325",
journal = "Seminars in Thrombosis and Hemostasis",
issn = "0094-6176",
publisher = "Thieme Medical Publishers",
number = "4",

}

TY - JOUR

T1 - The epidemiology of cancer-associated venous thromboembolism

T2 - An update

AU - Mahajan, Anjlee

AU - Brunson, Ann

AU - White, Richard H

AU - Wun, Theodore

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The incidence of venous thromboembolism (VTE) is known to be higher in patients with malignancy as compared with the general population. It is important to understand and review the epidemiology of VTE in cancer patients because it has implications regarding treatment and prognosis. Multiple studies have shown that cancer patients who develop VTE are at higher risk for mortality. This article will focus on an update regarding the epidemiology of cancer-associated thrombosis (CT). The authors will describe factors associated with CT risk including cancer type and stage at the time of diagnosis, race and ethnicity, and cancer-directed therapy. In addition, recurrent thrombosis and the effect of thromboembolism on survival in cancer patients will also be addressed.

AB - The incidence of venous thromboembolism (VTE) is known to be higher in patients with malignancy as compared with the general population. It is important to understand and review the epidemiology of VTE in cancer patients because it has implications regarding treatment and prognosis. Multiple studies have shown that cancer patients who develop VTE are at higher risk for mortality. This article will focus on an update regarding the epidemiology of cancer-associated thrombosis (CT). The authors will describe factors associated with CT risk including cancer type and stage at the time of diagnosis, race and ethnicity, and cancer-directed therapy. In addition, recurrent thrombosis and the effect of thromboembolism on survival in cancer patients will also be addressed.

KW - cancer-associated thrombosis

KW - epidemiology

KW - pulmonary embolism

KW - venous thrombosis

UR - http://www.scopus.com/inward/record.url?scp=85066923307&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066923307&partnerID=8YFLogxK

U2 - 10.1055/s-0039-1688494

DO - 10.1055/s-0039-1688494

M3 - Review article

C2 - 31041801

AN - SCOPUS:85066923307

VL - 45

SP - 321

EP - 325

JO - Seminars in Thrombosis and Hemostasis

JF - Seminars in Thrombosis and Hemostasis

SN - 0094-6176

IS - 4

ER -